Stocks/Funds/CIK 2104501

Remedium Capital Partners, LLC

concentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 2104501
Assets
$281M
Holdings
6
Lifetime alpha vs market
+417.20% annual
Average hold time
0.5 yr
median 0.5 yr

Quarterly history

Cum return +44% vs S&P -4% · α +49% lifetimeAUM $281M · peak $281MFlow $36M (+21%)2025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
+0.42%
adds into rallies
when a holding rises +10%+

Top positions · 6

Ticker$ value% portYoYHold time
ORKAOruka Therapeutics, Inc.$77M27.3%0.5 yr
SYRESpyre Therapeutics, Inc.$73M26.1%0.5 yr
DMRAGalecto, Inc.$53M18.8%0.5 yr
$49M17.5%0.5 yr
JBIOJade Biosciences, Inc.$22M7.9%0.5 yr
GLYCGlycoMimetics, Inc.$7M2.4%0.5 yr

Portfolio composition (YoY)

Industry mix
Biotechnology82.5%$232M
Unknown17.5%$49M
Country
US82.5%
Unknown17.5%
Top 5: 97.6% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %

Losers

TickerPrev $PnLYoY %

Top buys this quarter · 2

DMRA Galecto, Inc.+$50M
ORKA Oruka Therapeutics, Inc.+$1M

Top sells this quarter · 0

No sells this quarter

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$281M6+44.21%-4.37%+48.58%+0.04B
2025-12-31$170M6